This free Contract Pharma webinar on August 27 tackles the upstream manufacturing challenges that determine success in cell and gene therapy programs. Save your seat!
Drug development now costs $2.8 billion, with timelines expanding 26%. See how leading pharma labs are building unified data ecosystems that reduce errors and accelerate breakthroughs. Download the free white paper and explore what's next for R&D.
Nina Bauer of FUJIFILM Cellular Dynamics shares hands-on experience manufacturing iPSCs, their increasing importance, and the technical bottlenecks standing in their way.
This eBook looks at how reuse and redeployment can help companies save time, manage capital more effectively, and reduce environmental impact—without compromising quality or compliance.
FAMAR is a leading European CDMO with over 75 years of experience, providing end-to-end solutions for the pharmaceutical and healthcare industries. With 7 manufacturing sites and 2 R&D centers across Germany, Greece, Italy, and Spain, it delivers quality, compliance and value across a broad portfolio of finished dosage forms.
Contract packaging demands flexibility, efficiency, and control. At Praxis, we deliver all three through the innovative, cost effective application of manual labor and the skillful use of automated and custom packaging equipment. We've been doing so for about a quarter century. Our OTC/Rx pharmaceutical, consumer products, and medical device customers choose us for four reasons: a relentless focus on compliance, astonishing speed-to-market, unyielding accountability, and significant category experience. At Praxis, we don't just deliver innovative, turnkey packaging solutions. We provide them while exceeding our customers' expectations, while managing their critical deadlines, and while upholding rigorous regulatory and quality standards. You could call it agility; we call it Managed Rapid Response, and here at Praxis, it's at the heart of what we do. Upholding standards is so deeply engrained at Praxis that, since the company was formed, we've had exactly zero recalls.
